It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objectives: Non-tuberculous mycobacteria (NTM) are abundant in our environment. Geographic distribution of NTM species vary between continents and countries. These differences might drive local epidemiology of NTM disease and guide essential knowledge for daily clinical practice. However, significant knowledge gap exists concerning geographic distribution of NTM species. Infections with NTM represent an increasingly recognized problem in humans. We aimed to characterize clinical and microbiologic characteristics of the NTM isolates causing pulmonary disease in our center for the last two years.
Methods: Retrospective cohort study of NTM - pulmonary disease (NTM-PD), between January 2016 – December 2017. NTM – PD diagnosis was made using the ATS/IDSA diagnostic criteria. Clinical, radiological and bacteriological findings, all-cause mortality and mortality due to NTM-PD patients were recorded.
Results: A total of 41 patients (median 59.0 (IQR 25 -75: 42.5 – 71.5)) years old (29 males, 70.7%) diagnosed with NTM disease were included. Of those, 35 patients were diagnosed with NTM-pulmonary disease (NTM-PD). Slowly growing NTM (n=20, 60.6%) were more frequent compared to rapidly growing NTM (n=13, 39.4%), p=0.063. The most frequently identified NTM species were M. fortuitum (n=9, 25.7%), M. lentiflavum (n=7, 20.0%), followed by M. abscessuss (n=4, 11.4%) and M. kansasii (n=4, 11.4%), respectively. 9 (36.4%) patients had fibro-cavitary disease; whereas 17 (65.3%) had nodular-bronchiectatic disease. All-cause mortality was 34.3%, and was similar between slowly growing (n=7, 21.2%) vs. rapidly growing NTM-PD (n=4, 12.1%), respectively (p=0.801).
Conclusion: MAC and M. gordonae were the most frequently isolated NTM species worldwide and Turkey, respectively. Contrastingly, distribution of the NTM species in our center were different than worldwide and countrywide distribution patterns. The clinical relevance of geographic diversity and predictors for mortality are still largely unknown in NTM patients, further research is warranted.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer